VEMLIDY Drug Profile, 2024: VEMLIDY (tenofovir alafenamide fumarate) drug patents, FDA exclusivity, litigation, drug prices

By DrugPatentWatch

VEMLIDY Drug Profile, 2024

This report focuses on VEMLIDY and covers the following critical aspects of this drug:

United States patentsExpired United States patentsDistrict Court patent litigationEuropean supplementary protection certificates (SPCs)Clinical trialsDrug pricesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesFREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

• Format: Paperback
• Language: English
• ISBN: B0CS6NRRY1
• ISBN13: 9798875836947
• Release Date: January 2024
• Publisher: Independently Published
• Length: 132 Pages
• Weight: 0.71 lbs.
• Dimensions: 0.3" x 8.5" x 11.0"